M&A Deal Summary |
|
|---|---|
| Date | 2008-11-17 |
| Target | AstraZeneca - Biotech Laboratory |
| Sector | Life Science |
| Buyer(s) | Recipharm |
| Sellers(s) | AstraZeneca |
| Deal Type | Divestiture |
SEARCH BY
Recipharm is a global Pharma CDMO providing a full-service offering to leading Pharmaceutical companies and Biotechs globally. Recipharm was founded in 1995 and is based in Stockholm, Sweden.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 18 |
| Sector: Life Science M&A | 3 of 12 |
| Type: Divestiture M&A Deals | 2 of 8 |
| Country: Sweden M&A | 1 of 3 |
| Year: 2008 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-10-30 |
Laboratoires Fournier - Production Site
Fontaine-lès-Dijon, France Laboratoires Fournier - Production Site comprises tablet, capsule and manufacturing facilities as well as a modern logistics centre. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-12-16 |
Cobra Biomanufacturing
Keele, United Kingdom Cobra Biomanufacturing plc is a provider of biologics and pharmaceuticals contract manufacturing services. Company offers stand-alone services in the areas of cell line development, GMP cell banking, stability testing, protein characterization, bioassays, analytical services. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1992 |
| Sector | Life Science |
| Employees | 83,100 |
| Revenue | 54.1B USD (2024) |
AstraZeneca is a global biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in several major disease areas, including oncology, cardiovascular, renal & metabolism, and respiratory & immunology. AstraZeneca was founded in 1992 and is based in Cambridge, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 11 |
| Sector: Life Science M&A | 1 of 7 |
| Type: Divestiture M&A Deals | 1 of 11 |
| Country: Sweden M&A | 1 of 2 |
| Year: 2008 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-06-04 |
DSM Biologics - Manufacturing Facility
Canada The facility, occupying 66,000 sq. ft, will be used to manufacture antibody drug candidates for clinical trials and will serve the whole of the AstraZeneca group. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-08-31 |
Astra Tech AB
Molndal, Sweden Astra Tech AB is a provider of dental implants, customized implant abutments, and urology and surgery products. |
Sell | - |
